Management of Cisplatin-lnduced Delayed Emesis

Oncology (Switzerland)

Volumn 53, Issue 1, 1996, Pages 73-77

  Hesketh, P ^a  

^a ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

Antiemetics; Chemotherapy; Cisplatin; Delayed emesis; Nausea

Indexed keywords

ANTIEMETIC AGENT; CISPLATIN; CORTICOTROPIN; DEXAMETHASONE; GRANISETRON; METOCLOPRAMIDE; ONDANSETRON; SEROTONIN 3 ANTAGONIST;

ANTIEMETIC ACTIVITY; CANCER CHEMOTHERAPY; CLINICAL TRIAL; CONFERENCE PAPER; DRUG INDUCED DISEASE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; VOMITING;

ANTIEMETICS; ANTINEOPLASTIC AGENTS; CISPLATIN; CLINICAL TRIALS; HUMANS; SEROTONIN ANTAGONISTS; TIME FACTORS; VOMITING;

EID: 0029813534     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000227644     Document Type: Article

References (14)

1. Kris MG, Gralla RJ, Clark RA, Tyson I.B, O'Connell JP, Wcrtheim MS, Kelsen DP: Incidence, course and severity of delayed nausea and vomiting following the administration of high-dosc cisplatin, J Clin Oncol 1985:3:1379-1384.
2. Marty M, Pouillart P, Scholl S, Droz JP, Azab M, Brion N, Pujade-Lauraine E, Paulc B, Paes D, Bons J: Comparison of the 5-hydroxytrypta-mine-3 (serotonin) antagonist ondansetron (GR 38032F) with high-dosc mctoclopramide in the control of cisplatin-induced emesis, N Engl J Med 1990:322:816-821.
3. De Mulder PHM, Seynaeve C, Vermorkcn JB, van Liessum PA, Mols-Jevdcvic S, Lane All-man E, Beranek P, Verweij J: Ondansetron compared with high-dose metociopramide in the prophylaxis of acutc and delayed cisplatin-induced nausea and vomiting - A multicentre randomised, double-blind crossover study, Ann Intern Med 1990; 113:834-840.
4. Morran C, Smith DC, Anderson DA, McArdle CS: Incidence of nausea and vomiting with cytotoxic chemotherapy: A prospective randomised trial of antiemetics, Br Med J 1979:1: 1323-1324.
5. Kris MG, Gralla RJ, Tyson LB, Clark RA, Cir-rincione C, Groshcn S: Controlling delayed vomiting: Double-blind, randomised trial comparing placebo, dexamethasone alone and mctoclopramide plus dexamethasone in patients receiving cisplatin, J Clin Oncol 1989:7:108-114.
6. Shinkai T, Saijo N, Eguchi K, Sasaki Y, Tamu-ra T, Fujiwara Y, Mac M, Fukuda M, Ohc Y, Sasaki S, Nakuhiko K, Minato K, Hong W-S, Suemasu K: Control of cisplatin-induced delayed cmesis with metociopramide and dcxamcthasone: A randomised controlled trial, Jpn J Clin Oncol 1989;19:40-44.
7. Roila F, Boschctti E, Tonato M, Basurto C, Bracarda S, Picciafuoco M, Patoia L, Santi E, Penza O, Ballatori E, del Favero A: Predictive factors of delayed emesis in cisplatin-treated patients and anticmctic activity and tolerabili-ty of metociopramide or dexamethasone, Am J Clin Oncol 1991;14:238-242.
8. Passalacqua R, Cocconi G, Bella M, Monici L, Michiara M, Bandini N, Bacchi M: Double-blind, randomized trial for the control of delayed emesis in patients receiving cisplatin: Comparison of placebo vs, adrenocorticotropic hormone, Ann Oncol 1992:3:481-485.
9. Roila F, Italian Group for Anticmetic Research: Ondansetron + dexamethasone vs, me-toclopramidc + dexamethasone + diphenhydramine in the prevention of cisplatin-induced emesis, Lancet 1992;340:96-99.
10. Schneider M: Incidence of delayed cisplatin-induced emesis following acute anti-emetic prophylaxis with granisctron: A historical review, SmithKline Beecham Satellite Symp 15th ICC, 1990, pp 19-21.
11. Roila F, Bracarda S, Tonato M, Marangolo M, Bella M, Donati D, Cetto G, Del Favero A: Ondansetron (GR38032) in the prophylaxis of acutc and delayed cisplatin-induced emesis, Clin Oncol 1990;2:268-272.
12. Kris MG, Tyson LB, Clark RA, Gralla RJ: Oral ondansetron for the control of delayed emesis after cisplatin, Report of phase II study and a review of completed trials to manage delayed emesis, Cancer 1992:70:1012-1016.
13. Smyth J: Delayed emesis after high-dose cisplatin - The residual problem, SmithKline Beecham Satellite Symp ESMO, 1992, pp 24-26.
14. Gandara DR, Harvey WH, Monaghan GG, Perez F.A, Stokes C, Bryson JC, Finn AL, Hes-keth PJ: The delaycd-cmesis syndrome from cisplatin: Phase III evaluation of ondansetron versus placebo, Semin Oncol 1992; 19(suppl 10):67-71.